Beiersdorf Aktiengesellschaft (VIE:BEI)
Austria · Delayed Price · Currency is EUR | Market Cap | 15.76B -39.0% |
| Revenue (ttm) | 9.85B +0.0% |
| Net Income | 939.00M +3.0% |
| EPS | 4.25 +4.8% |
| Shares Out | n/a |
| PE Ratio | 16.79 |
| Forward PE | 16.70 |
| Dividend | 1.00 (1.35%) |
| Ex-Dividend Date | Apr 24, 2026 |
| Volume | 50 |
| Average Volume | 182 |
| Open | 72.26 |
| Previous Close | 72.52 |
| Day's Range | 71.96 - 72.34 |
| 52-Week Range | 71.74 - 127.10 |
| Beta | n/a |
| RSI | 34.07 |
| Earnings Date | Apr 21, 2026 |
About VIE:BEI
Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia. The company operates through two segments: Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive solutions for industries, craft businesses, and consumers. This segment also offers its system solutions to the automotive, consumer electronics, printing and packaging, ... [Read more]
Financial Performance
In 2025, VIE:BEI's revenue was 9.85 billion, an increase of 0.02% compared to the previous year's 9.85 billion. Earnings were 939.00 million, an increase of 2.96%.
Financial StatementsNews
Beiersdorf Aktiengesellschaft Transcript: AGM 2026
The AGM highlighted solid financials amid a challenging market, with strategic focus on NIVEA rebalancing, innovation, and expansion in key markets. All management proposals, including dividend and remuneration, were approved by strong majorities. Shareholders raised concerns on share price, acquisitions, and product strategy, which management addressed in detail.
Beiersdorf AG (BDRFF) Q1 2026 Earnings Call Highlights: Navigating Sales Declines and Strategic ...
Beiersdorf AG (BDRFF) Q1 2026 Earnings Call Highlights: Navigating Sales Declines and Strategic Growth
Q1 2026 Beiersdorf AG Earnings Call Transcript
Q1 2026 Beiersdorf AG Earnings Call Transcript
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw a 4.6% organic net sales decline, with Derma delivering strong growth and Nivea and La Prairie facing headwinds. Early signs of improved sell-out and ongoing strategic rebalancing support a cautiously optimistic outlook for the year.
Beiersdorf Q1 Sales Down; Confirms Full-year Outlook
BRUSSELS (dpa-AFX) - Beiersdorf AG (BDRFF.PK) on Tuesday reported lower group sales in the first quarter of 2026, reflecting declines across all regions.Total sales fell 7.7% to €2.484 billion fro...
Is Beiersdorf stock a buy after 44% crash? UBS upgrade offers key signals
Beiersdorf stock's long slump has finally been enough to make one major broker step back from its bearish stance. UBS upgraded the German skincare and consumer-goods group to “neutral” from “sell” on ...
Beiersdorf Shares Fall on Sluggish 2026 Outlook
The cosmetics company expects slow sales this year, particularly in its consumer business segment.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2025
Despite a challenging year marked by market slowdowns and cost pressures, the group delivered modest sales and profit growth, driven by strong Derma performance and innovation. Strategic repositioning of NIVEA and continued investment in R&D and shareholder returns are key priorities.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q3 2025
Group organic sales grew 1.7% in Q3, led by double-digit derma growth, while NIVEA faced mass market headwinds but saw strong September momentum from new launches. Full-year guidance was adjusted to 2.5% organic growth, with EBIT margin improvement expected.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2025
Group organic sales grew 2.1% in H1 2025, with strong Derma and Healthcare segments offsetting NIVEA's softness. Major innovation launches, especially EPICELLINE, are set to drive a stronger H2, though full-year Consumer growth guidance was lowered to 3%-4%.
Nivea-maker Beiersdorf's shares fall on lower sales forecast
Nivea-maker Beiersdorf's shares fell 10% on Wednesday after the company lowered its 2025 sales growth forecast late on Tuesday and warned of difficult market conditions.
Switzerland investigates Beiersdorf in dispute over Nivea pricing
The Swiss competition authority said on Tuesday it has opened an investigation into Beiersdorf over whether the German consumer goods group has relative market power over Swiss retailer Migros in a di...
Beiersdorf Sticks to Outlook After Solid Sales Growth
The personal-care products maker reported organic sales growth of 3.6% and backed its expectations for 2025.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2025
Group organic sales grew 3.6% in Q1, led by strong Derma and Tesa performance, while China repositioning and travel retail weighed on results. Guidance for 4%-6% organic growth and higher EBIT margin is maintained, with improvement expected in H2 as innovation launches accelerate.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2024
Record sales and profit growth in 2024, with strong performance in Consumer and Derma segments, margin expansion, and continued innovation. 2025 guidance anticipates 4%-6% organic growth, margin improvement, and ongoing investment in sustainability and digital.
Beiersdorf expects organic growth to slow in 2025
Nivea maker Beiersdorf on Thursday said it expected organic growth to slow in the current year, citing weaker demand in the global skin care market.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q3 2024
Group organic sales grew 6.5% in the first nine months, led by strong Nivea and Derma performance, while La Prairie faced headwinds in China. Full-year guidance is confirmed, with optimism for Q4 and 2025 driven by innovation and balanced growth.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2024
Delivered 7.1% organic sales growth in H1 2024, led by NIVEA and Derma, with strong gains in emerging markets and e-commerce. Confirmed 6%-8% full-year growth guidance, despite luxury and sun care headwinds, and launched major innovations like Eucerin Epicelline.
Beiersdorf misses profit forecast, says slow China hit luxury brand sales
Nivea maker Beiersdorf missed expectations for half-year operating profit on Wednesday and said the luxury market slowdown in China had hit the sales of its La Prairie brand.
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
SAN FRANCISCO--(BUSINESS WIRE)-- #antiaging--Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging.
Beiersdorf Lifts Guidance After Strong Nivea Sales
Beiersdorf upgraded its full-year sales expectations after reporting a 10% revenue rise in its core consumer business in the first quarter.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2024
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2023
Beiersdorf warns of slowing sales growth
Nivea maker Beiersdorf on Thursday forecast a slowdown in organic sales growth to a mid-single-digit percentage in 2024, after reporting a 10.8% increase in the past year.